Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dexfenfluramine
2. Hydrochloride, Dexfenfluramine
3. Redux
1. 3239-45-0
2. Isomeride
3. Adipomin
4. (+)-fenfluramine Hydrochloride
5. Adifax
6. Redux
7. D-fenfluramine Hydrochloride
8. Glypolix
9. Dexfenfluramine Hcl
10. S 5614 Hcl
11. Dexfenfluramine Hydrochloride [usan]
12. Pm28l0fhnp
13. (+)-(s)-n-ethyl-alpha-methyl-m-(trifluoromethyl)phenethylamine Hydrochloride
14. S-5614 Hcl
15. Dsstox_cid_28797
16. Dsstox_rid_83066
17. Dsstox_gsid_48871
18. Dexfenfluramine Hydrochloride (usan)
19. Chebi:59730
20. Dea No. 1670
21. Cas-3239-45-0
22. Ncgc00247710-01
23. Einecs 221-806-0
24. Unii-pm28l0fhnp
25. C12h16f3n.hcl
26. (s)-(+)-fenfluramine Hydrochloride
27. Redux (tn)
28. (s)-n-ethyl-alpha-methyl-m-(trifluoromethyl)phenethylamine Hydrochloride
29. Mls002320658
30. Schembl120916
31. S-5614 Hydrochloride
32. Chembl1887891
33. Dtxsid7048871
34. Dexfenfluramine Hydrochloride- Bio-x
35. Tox21_112864
36. Ip-001
37. Akos024457243
38. Tox21_112864_1
39. Ccg-220638
40. Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, Hydrochloride, (s)-
41. Fenfluramine D-form Hydrochloride
42. Ncgc00247710-02
43. Bf164363
44. Smr001338809
45. Dexfenfluramine Hydrochloride [mart.]
46. Dexfenfluramine Hydrochloride [vandf]
47. Ft-0653919
48. Dexfenfluramine Hydrochloride [who-dd]
49. Fenfluramine D-form Hydrochloride [mi]
50. D03713
51. S-5614
52. 239d450
53. Sr-01000868883
54. Sr-01000868883-2
55. Q27126873
56. (2s)-n-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine;hydrochloride
57. (s)-n-ethyl-?-methyl-3-(trifluoromethyl)benzeneethanamine Hydrochloride
58. (s)-n-ethyl-1-(3-(trifluoromethyl)phenyl)propan-2-amine Hydrochloride
59. (s)-n-ethyl-a-methyl-3-(trifluoromethyl)benzeneethanamine Hydrochloride
60. (s)-n-ethyl-alpha-methyl-3-(trifluoromet Hyl)benzeneethanamine Hydrochloride
61. (+)-(s)-n-ethyl-.alpha.-methyl-m-(trifluoromethyl)phenethylamine Hydrochloride
62. Benzeneethanamine, N-ethyl-.alpha.-methyl-3-(trifluoromethyl)-, Hydrochloride, (s)-
63. Benzeneethanamine, N-ethyl-.alpha.-methyl-3-(trifluoromethyl)-, Hydrochloride, (.alpha.s)-
Molecular Weight | 267.72 g/mol |
---|---|
Molecular Formula | C12H17ClF3N |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 267.1001617 g/mol |
Monoisotopic Mass | 267.1001617 g/mol |
Topological Polar Surface Area | 12 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 203 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Serotonin Receptor Agonists
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)
ABOUT THIS PAGE
A Dexfenfluramine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dexfenfluramine, including repackagers and relabelers. The FDA regulates Dexfenfluramine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dexfenfluramine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dexfenfluramine supplier is an individual or a company that provides Dexfenfluramine active pharmaceutical ingredient (API) or Dexfenfluramine finished formulations upon request. The Dexfenfluramine suppliers may include Dexfenfluramine API manufacturers, exporters, distributors and traders.
click here to find a list of Dexfenfluramine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dexfenfluramine DMF (Drug Master File) is a document detailing the whole manufacturing process of Dexfenfluramine active pharmaceutical ingredient (API) in detail. Different forms of Dexfenfluramine DMFs exist exist since differing nations have different regulations, such as Dexfenfluramine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dexfenfluramine DMF submitted to regulatory agencies in the US is known as a USDMF. Dexfenfluramine USDMF includes data on Dexfenfluramine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dexfenfluramine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dexfenfluramine suppliers with USDMF on PharmaCompass.
Dexfenfluramine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dexfenfluramine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dexfenfluramine GMP manufacturer or Dexfenfluramine GMP API supplier for your needs.
A Dexfenfluramine CoA (Certificate of Analysis) is a formal document that attests to Dexfenfluramine's compliance with Dexfenfluramine specifications and serves as a tool for batch-level quality control.
Dexfenfluramine CoA mostly includes findings from lab analyses of a specific batch. For each Dexfenfluramine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dexfenfluramine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dexfenfluramine EP), Dexfenfluramine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dexfenfluramine USP).
LOOKING FOR A SUPPLIER?